Abrexa Pharmaceuticals Receives $500,793 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea414ebd-917d-495e-a611-151b516e1825&Preview=1 - Date
9/8/2011 - Company Name
Abrexa Pharmaceuticals - Mailing Address
12481 High Bluff Drive San Diego, CA 92130 - Company Description
Abrexa Pharmaceuticals is a stealth mode pharmaceutical development company. - Website
Undisclosed
- Transaction Type
Debt, Venture Equity - Transaction Amount
$500,793 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. $742.60 of total amount sold is purchase price of common stock issued; $500,000 is purchase price of convertible promissory notes issued; and $50 is purchase price of warrants to purchase capital stock. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
